<!DOCTYPE html><html><head><title> Pacifica Code Section 26-61a-S301 </title><link rel="stylesheet" href="/assets/style.css"/></head><body>
<b><i>
                      Effective 3/23/2022</i></b>
<br>
<b>26-61a-301.&nbsp;
          </b><b>Medical cannabis pharmacy -- License -- Eligibility.</b>
<br>
<a id="26-61a-301(1)" name="26-61a-301(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
A person may not operate as a medical cannabis pharmacy without a license that the department issues under this part.</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)" name="26-61a-301(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%"><a id="26-61a-301(2)(a)" name="26-61a-301(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%"><a id="26-61a-301(2)(a)(i)" name="26-61a-301(2)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
Subject to Subsections <a href="#26-61a-301(4)">(4)</a> and <a href="#26-61a-301(5)">(5)</a> and to Section <a href="../../Title26/Chapter61A/26-61a-S305.html?v=C26-61a-S305_2022032320220323">26-61a-305</a>, the department shall issue a license to operate a medical cannabis pharmacy in accordance with <a href="../../Title63G/Chapter6A/63G-6a.html?v=C63G-6a_1800010118000101">Title 63G, Chapter 6a, Utah Procurement Code</a>.</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(a)(ii)" name="26-61a-301(2)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
The department may not issue a license to operate a medical cannabis pharmacy to an applicant who is not eligible for a license under this section.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(b)" name="26-61a-301(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
An applicant is eligible for a license under this section if the applicant submits to the department:<a id="26-61a-301(2)(b)(i)" name="26-61a-301(2)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
subject to Subsection <a href="#26-61a-301(2)(c)">(2)(c)</a>, a proposed name and address where the applicant will operate the medical cannabis pharmacy;</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(b)(ii)" name="26-61a-301(2)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the name and address of an individual who:
<a id="26-61a-301(2)(b)(ii)(A)" name="26-61a-301(2)(b)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
for a publicly traded company, has a financial or voting interest of 2% or greater in the proposed medical cannabis pharmacy;</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(b)(ii)(B)" name="26-61a-301(2)(b)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
for a privately held company, a financial or voting interest in the proposed medical cannabis pharmacy; or</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(b)(ii)(C)" name="26-61a-301(2)(b)(ii)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
has the power to direct or cause the management or control of a proposed medical cannabis pharmacy;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(b)(iii)" name="26-61a-301(2)(b)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
a statement that the applicant will obtain and maintain a performance bond that a surety authorized to transact surety business in the state issues in an amount of at least $100,000 for each application that the applicant submits to the department;</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(b)(iv)" name="26-61a-301(2)(b)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
an operating plan that:
<a id="26-61a-301(2)(b)(iv)(A)" name="26-61a-301(2)(b)(iv)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
complies with Section <a href="../../Title26/Chapter61A/26-61a-S304.html?v=C26-61a-S304_2019092320190923">26-61a-304</a>;</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(b)(iv)(B)" name="26-61a-301(2)(b)(iv)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
includes operating procedures to comply with the operating requirements for a medical cannabis pharmacy described in this chapter and with a relevant municipal or county law that is consistent with Section <a href="../../Title26/Chapter61A/26-61a-S507.html?v=C26-61a-S507_2020022820200228">26-61a-507</a>; and</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(b)(iv)(C)" name="26-61a-301(2)(b)(iv)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
the department approves;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(b)(v)" name="26-61a-301(2)(b)(v)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(v)</td><td style="width:99%">
an application fee in an amount that, subject to Subsection <a href="../../Title26/Chapter61A/26-61a-S109.html?v=C26-61a-S109_2019092320190923#26-61a-109(5)">26-61a-109(5)</a>, the department sets in accordance with Section <a href="../../Title63J/Chapter1/63J-1-S504.html?v=C63J-1-S504_2022050420220504">63J-1-504</a>; and</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(b)(vi)" name="26-61a-301(2)(b)(vi)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(vi)</td><td style="width:99%">
a description of any investigation or adverse action taken by any licensing jurisdiction, government agency, law enforcement agency, or court in any state for any violation or detrimental conduct in relation to any of the applicant's cannabis-related operations or businesses.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(c)" name="26-61a-301(2)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%"><a id="26-61a-301(2)(c)(i)" name="26-61a-301(2)(c)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
A person may not locate a medical cannabis pharmacy:
<a id="26-61a-301(2)(c)(i)(A)" name="26-61a-301(2)(c)(i)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
within 200 feet of a community location; or</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(c)(i)(B)" name="26-61a-301(2)(c)(i)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
in or within 600 feet of a district that the relevant municipality or county has zoned as primarily residential.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(c)(ii)" name="26-61a-301(2)(c)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
The proximity requirements described in Subsection <a href="#26-61a-301(2)(c)(i)">(2)(c)(i)</a> shall be measured from the nearest entrance to the medical cannabis pharmacy establishment by following the shortest route of ordinary pedestrian travel to the property boundary of the community location or residential area.</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(c)(iii)" name="26-61a-301(2)(c)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
The department may grant a waiver to reduce the proximity requirements in Subsection <a href="#26-61a-301(2)(c)(i)">(2)(c)(i)</a> by up to 20% if the department determines that it is not reasonably feasible for the applicant to site the proposed medical cannabis pharmacy without the waiver.</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(c)(iv)" name="26-61a-301(2)(c)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
An applicant for a license under this section shall provide evidence of compliance with the proximity requirements described in Subsection <a href="#26-61a-301(2)(c)(i)">(2)(c)(i)</a>.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(d)" name="26-61a-301(2)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
The department may not issue a license to an eligible applicant that the department has selected to receive a license until the selected eligible applicant obtains the performance bond described in Subsection <a href="#26-61a-301(2)(b)(iii)">(2)(b)(iii)</a>.</td>
</tr>
</tbody></table>
<a id="26-61a-301(2)(e)" name="26-61a-301(2)(e)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(e)</td><td style="width:99%">
If the department receives more than one application for a medical cannabis pharmacy within the same city or town, the department shall consult with the local land use authority before approving any of the applications pertaining to that city or town.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(3)" name="26-61a-301(3)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(3)</td><td style="width:99%">
If the department selects an applicant for a medical cannabis pharmacy license under this section, the department shall:
<a id="26-61a-301(3)(a)" name="26-61a-301(3)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
charge the applicant an initial license fee in an amount that, subject to Subsection <a href="../../Title26/Chapter61A/26-61a-S109.html?v=C26-61a-S109_2019092320190923#26-61a-109(5)">26-61a-109(5)</a>, the department sets in accordance with Section <a href="../../Title63J/Chapter1/63J-1-S504.html?v=C63J-1-S504_2022050420220504">63J-1-504</a>;</td>
</tr>
</tbody></table>
<a id="26-61a-301(3)(b)" name="26-61a-301(3)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
notify the Department of Public Safety of the license approval and the names of each individual described in Subsection <a href="#26-61a-301(2)(b)(ii)">(2)(b)(ii)</a>; and</td>
</tr>
</tbody></table>
<a id="26-61a-301(3)(c)" name="26-61a-301(3)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
charge the licensee a fee in an amount that, subject to Subsection <a href="../../Title26/Chapter61A/26-61a-S109.html?v=C26-61a-S109_2019092320190923#26-61a-109(5)">26-61a-109(5)</a>, the department sets in accordance with Section <a href="../../Title63J/Chapter1/63J-1-S504.html?v=C63J-1-S504_2022050420220504">63J-1-504</a>, for any change in location, ownership, or company structure.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(4)" name="26-61a-301(4)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(4)</td><td style="width:99%">
The department may not issue a license to operate a medical cannabis pharmacy to an applicant if an individual described in Subsection <a href="#26-61a-301(2)(b)(ii)">(2)(b)(ii)</a>:
<a id="26-61a-301(4)(a)" name="26-61a-301(4)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
has been convicted under state or federal law of:<a id="26-61a-301(4)(a)(i)" name="26-61a-301(4)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
a felony; or</td>
</tr>
</tbody></table>
<a id="26-61a-301(4)(a)(ii)" name="26-61a-301(4)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
after December 3, 2018, a misdemeanor for drug distribution;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(4)(b)" name="26-61a-301(4)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
is younger than 21 years old; or</td>
</tr>
</tbody></table>
<a id="26-61a-301(4)(c)" name="26-61a-301(4)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
after September 23, 2019, until January 1, 2023, is actively serving as a legislator.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(5)" name="26-61a-301(5)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(5)</td><td style="width:99%"><a id="26-61a-301(5)(a)" name="26-61a-301(5)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
If an applicant for a medical cannabis pharmacy license under this section holds a license under <a href="../../Title4/Chapter41/4-41.html?v=C4-41_2019051420190514">Title 4, Chapter 41, Hemp and Cannabinoid Act</a>, the department may not give preference to the applicant based on the applicant's status as a holder of the license.</td>
</tr>
</tbody></table>
<a id="26-61a-301(5)(b)" name="26-61a-301(5)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
If an applicant for a medical cannabis pharmacy license under this section holds a license to operate a cannabis cultivation facility under <a href="../../Title4/Chapter41A/4-41a.html?v=C4-41a_2018120320181203">Title 4, Chapter 41a, Cannabis Production Establishments</a>, the department:<a id="26-61a-301(5)(b)(i)" name="26-61a-301(5)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
shall consult with the Department of Agriculture and Food regarding the applicant; and</td>
</tr>
</tbody></table>
<a id="26-61a-301(5)(b)(ii)" name="26-61a-301(5)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
may give consideration to the applicant based on the applicant's status as a holder of a license to operate a cannabis cultivation facility if:
<a id="26-61a-301(5)(b)(ii)(A)" name="26-61a-301(5)(b)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
the applicant demonstrates that a decrease in costs to patients is more likely to result from the applicant's vertical integration than from a more competitive marketplace; and</td>
</tr>
</tbody></table>
<a id="26-61a-301(5)(b)(ii)(B)" name="26-61a-301(5)(b)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
the department finds multiple other factors, in addition to the existing license, that support granting the new license.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(6)" name="26-61a-301(6)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(6)</td><td style="width:99%"><a id="26-61a-301(6)(a)" name="26-61a-301(6)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
The department may revoke a license under this part:<a id="26-61a-301(6)(a)(i)" name="26-61a-301(6)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
if the medical cannabis pharmacy does not begin operations within one year after the day on which the department issues an announcement of the department's intent to award a license to the medical cannabis pharmacy;</td>
</tr>
</tbody></table>
<a id="26-61a-301(6)(a)(ii)" name="26-61a-301(6)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
after the third the same violation of this chapter in any of the licensee's licensed cannabis production establishments or medical cannabis pharmacies;</td>
</tr>
</tbody></table>
<a id="26-61a-301(6)(a)(iii)" name="26-61a-301(6)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
if an individual described in Subsection <a href="#26-61a-301(2)(b)(ii)">(2)(b)(ii)</a> is convicted, while the license is active, under state or federal law of:
<a id="26-61a-301(6)(a)(iii)(A)" name="26-61a-301(6)(a)(iii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
a felony; or</td>
</tr>
</tbody></table>
<a id="26-61a-301(6)(a)(iii)(B)" name="26-61a-301(6)(a)(iii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
after December 3, 2018, a misdemeanor for drug distribution;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(6)(a)(iv)" name="26-61a-301(6)(a)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
if the licensee fails to provide the information described in Subsection <a href="#26-61a-301(2)(b)(vi)">(2)(b)(vi)</a> at the time of application, or fails to supplement the information described in Subsection <a href="#26-61a-301(2)(b)(vi)">(2)(b)(vi)</a> with any investigation or adverse action that occurs after the submission of the application within 14 calendar days after the licensee receives notice of the investigation or adverse action;</td>
</tr>
</tbody></table>
<a id="26-61a-301(6)(a)(v)" name="26-61a-301(6)(a)(v)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(v)</td><td style="width:99%">
if the medical cannabis pharmacy demonstrates a willful or reckless disregard for the requirements of this chapter or the rules the department makes in accordance with this chapter; or</td>
</tr>
</tbody></table>
<a id="26-61a-301(6)(a)(vi)" name="26-61a-301(6)(a)(vi)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(vi)</td><td style="width:99%">
if, after a change of ownership described in Subsection <a href="#26-61a-301(11)(c)">(11)(c)</a>, the department determines that the medical cannabis pharmacy no longer meets the minimum standards for licensure and operation of the medical cannabis pharmacy described in this chapter.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(6)(b)" name="26-61a-301(6)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
The department shall rescind a notice of an intent to issue a license under this part to an applicant or revoke a license issued under this part if the associated medical cannabis pharmacy does not begin operation on or before June 1, 2021.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(7)" name="26-61a-301(7)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(7)</td><td style="width:99%"><a id="26-61a-301(7)(a)" name="26-61a-301(7)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
A person who receives a medical cannabis pharmacy license under this chapter, if the municipality or county where the licensed medical cannabis pharmacy will be located requires a local land use permit, shall submit to the department a copy of the licensee's approved application for the land use permit within 120 days after the day on which the department issues the license.</td>
</tr>
</tbody></table>
<a id="26-61a-301(7)(b)" name="26-61a-301(7)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
If a licensee fails to submit to the department a copy the licensee's approved land use permit application in accordance with Subsection <a href="#26-61a-301(7)(a)">(7)(a)</a>, the department may revoke the licensee's license.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(8)" name="26-61a-301(8)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(8)</td><td style="width:99%">
The department shall deposit the proceeds of a fee imposed by this section into the Qualified Patient Enterprise Fund.</td>
</tr>
</tbody></table>
<a id="26-61a-301(9)" name="26-61a-301(9)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(9)</td><td style="width:99%">
The department shall begin accepting applications under this part on or before March 1, 2020.</td>
</tr>
</tbody></table>
<a id="26-61a-301(10)" name="26-61a-301(10)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(10)</td><td style="width:99%"><a id="26-61a-301(10)(a)" name="26-61a-301(10)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
The department's authority to issue a license under this section is plenary and is not subject to review.</td>
</tr>
</tbody></table>
<a id="26-61a-301(10)(b)" name="26-61a-301(10)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
Notwithstanding Subsection <a href="#26-61a-301(2)">(2)</a>, the decision of the department to award a license to an applicant is not subject to:<a id="26-61a-301(10)(b)(i)" name="26-61a-301(10)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%"><a href="../../Title63G/Chapter6A/63G-6a-P16.html?v=C63G-6a-P16_2016032820160328">Title 63G, Chapter 6a, Part 16, Protests</a>; or</td>
</tr>
</tbody></table>
<a id="26-61a-301(10)(b)(ii)" name="26-61a-301(10)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%"><a href="../../Title63G/Chapter6A/63G-6a-P17.html?v=C63G-6a-P17_1800010118000101">Title 63G, Chapter 6a, Part 17, Procurement Appeals Board</a>.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(11)" name="26-61a-301(11)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(11)</td><td style="width:99%"><a id="26-61a-301(11)(a)" name="26-61a-301(11)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
A medical cannabis pharmacy license is not transferrable or assignable.</td>
</tr>
</tbody></table>
<a id="26-61a-301(11)(b)" name="26-61a-301(11)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
A medical cannabis pharmacy shall report in writing to the department no later than 10 business days before the date of any change of ownership of the medical cannabis pharmacy.</td>
</tr>
</tbody></table>
<a id="26-61a-301(11)(c)" name="26-61a-301(11)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
If the ownership of a medical cannabis pharmacy changes by 50% or more:<a id="26-61a-301(11)(c)(i)" name="26-61a-301(11)(c)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
concurrent with the report described in Subsection <a href="#26-61a-301(11)(b)">(11)(b)</a>, the medical cannabis pharmacy shall submit a new application described in Subsection <a href="#26-61a-301(2)(b)">(2)(b)</a>, subject to Subsection <a href="#26-61a-301(2)(c)">(2)(c)</a>;</td>
</tr>
</tbody></table>
<a id="26-61a-301(11)(c)(ii)" name="26-61a-301(11)(c)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
within 30 days of the submission of the application, the department shall:
<a id="26-61a-301(11)(c)(ii)(A)" name="26-61a-301(11)(c)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
conduct an application review; and</td>
</tr>
</tbody></table>
<a id="26-61a-301(11)(c)(ii)(B)" name="26-61a-301(11)(c)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
award a license to the medical cannabis pharmacy for the remainder of the term of the medical cannabis pharmacy's license before the ownership change if the medical cannabis pharmacy meets the minimum standards for licensure and operation of the medical cannabis pharmacy described in this chapter; and</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-61a-301(11)(c)(iii)" name="26-61a-301(11)(c)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
if the department approves the license application, notwithstanding Subsection <a href="#26-61a-301(3)">(3)</a>, the medical cannabis pharmacy shall pay a license fee that the department sets in accordance with Section <a href="../../Title63J/Chapter1/63J-1-S504.html?v=C63J-1-S504_2022050420220504">63J-1-504</a> in an amount that covers the board's cost of conducting the application review.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=290&amp;sess=2022GS">290</a>, 2022 General Session<br>
</body></html>